No abstract available
MeSH terms
-
Administration, Oral
-
Adrenergic alpha-Antagonists / chemical synthesis*
-
Adrenergic alpha-Antagonists / metabolism
-
Adrenergic alpha-Antagonists / pharmacokinetics
-
Adrenergic alpha-Antagonists / pharmacology
-
Animals
-
Aorta / drug effects
-
Aorta / physiology
-
Binding, Competitive
-
Biological Availability
-
Blood Pressure / drug effects
-
Dogs
-
Humans
-
In Vitro Techniques
-
Male
-
Muscle Contraction / drug effects
-
Muscle, Smooth / drug effects
-
Muscle, Smooth / physiology
-
Oxazoles / chemical synthesis*
-
Oxazoles / metabolism
-
Oxazoles / pharmacokinetics
-
Oxazoles / pharmacology
-
Pressure
-
Prostate / drug effects
-
Prostate / physiology
-
Radioligand Assay
-
Rats
-
Receptors, Adrenergic, alpha-1 / drug effects*
-
Recombinant Proteins / chemical synthesis
-
Recombinant Proteins / metabolism
-
Recombinant Proteins / pharmacokinetics
-
Recombinant Proteins / pharmacology
-
Urethra / drug effects
-
Urethra / physiology
Substances
-
ADRA1A protein, human
-
Adrenergic alpha-Antagonists
-
Oxazoles
-
Receptors, Adrenergic, alpha-1
-
Recombinant Proteins
-
SNAP 7915